Study may offer an unexpected pathway for targeted treatment of brain tumors

[News]

In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody.

More... (https://www.news-medical.net/news/20210615/Study-may-offer-an-unexpected-pathway-for-targeted-treatment-of-brain-tumors.aspx)